NYSEMKT: AIM
Aim Immunotech Inc Stock Ownership - Who owns Aim Immunotech?

Insider buying vs selling

Have Aim Immunotech Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
David I. ChemerowDirector2026-02-052,800$1.23
$3.44kBuy
Thomas K. EquelsCEO President2025-06-13107$7.70
$823.58Buy
Thomas K. EquelsCEO President2025-06-12103$8.70
$896.10Buy

1 of 1

AIM insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AIM insiders and whales buy or sell their stock.

AIM Shareholders

What type of owners hold Aim Immunotech Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ted D. Kellner58.60%4,774,709$2.68MInsider
William A. Carter25.97%2,116,170$1.19MInsider
Iraj Eqhbal Kiani7.74%630,886$354.56kInsider
William M. 1. Mitchell6.41%522,103$293.42kInsider
Peter W. Rodino Iii4.93%401,762$225.79kInsider
Stewart Appelrouth4.77%388,729$218.47kInsider
Nancy Bryan3.58%291,882$164.04kInsider
Steven D. Spence2.57%209,410$117.69kInsider
Russel J. Lander2.55%207,983$116.89kInsider
Charles Thomas Bernhardt Iii2.18%177,420$99.71kInsider

1 of 3

AIM vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AIM1.03%98.97%Net BuyingNet Buying
CLGN10.77%2.64%
PULM4.99%95.01%
ALZN0.69%99.31%Net BuyingNet Buying
REVB12.55%87.45%Net BuyingNet Selling

Aim Immunotech Stock Ownership FAQ

Who owns Aim Immunotech?

Aim Immunotech (NYSEMKT: AIM) is owned by 1.30% institutional shareholders, 124.88% Aim Immunotech insiders, and 0.00% retail investors. Ted D. Kellner is the largest individual Aim Immunotech shareholder, owning 4.77M shares representing 58.60% of the company. Ted D. Kellner's Aim Immunotech shares are currently valued at $2.60M.

If you're new to stock investing, here's how to buy Aim Immunotech stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.